PR84913

YOKNEAM, Israel, July, 28 /PRNewswire=KYODO JBN/ --

- TIGERTRIEVER XL is the largest stentriever available, designed to safely

remove clots from intracranial vessels up to 9mm in diameter

Rapid Medical [http://www.rapid-medical.com/], a company focused on the

development of next generation neurovascular devices, has announced that it

received CE Mark for TIGERTRIEVER XL. In addition, the first patients have been

treated successfully with the device.

The TIGERTRIEVER family of stentrievers are the first-ever adjustable, fully

visible clot retrievers designed to treat ischemic stroke. Thousands of

patients have been successfully treated with TIGERTRIEVER to date. TIGERTRIEVER

XL is the newest addition to the portfolio. Its adjustable diameter can conform

to any vessel diameter up to 9mm and at 53mm in length, it is the largest and

the longest stentriever available. Although significantly larger than other

similar devices on the market, it is easily delivered via a standard

microcatheter with an internal diameter of 0.021".

"TIGERTRIEVER XL is a very important addition to the ischemic stroke market,"

said Dr. Sebastian Fischer, a senior Interventional Neuroradiologist at Bochum

University Hospital, Germany. "For the first time, we have a tool that can be

adjusted to these dimensions and is dedicated to retrieve large clot loads.

This is an important addition to our current tool set, since it can potentially

reduce the number of passes required to remove large stroke-causing clots, for

example, in the internal carotid artery."

Ronen Eckhouse, CEO of Rapid Medical commented on the first clinical experience

with TIGERTRIEVER XL: "TIGERTRIEVER XL is another example of our powerful

technology that adjusts to the vessel diameter for full clot removal in the

treatment large vessel occlusion. TIGERTRIEVER XL compliments TIGERTRIEVER 13,

the smallest stentriever available today, and the only stentriever indicated

for distal vessel occlusion. The TIGERTRIEVER portfolio now allows surgeons to

treat ischemic stroke in the majority of vessels where it occurs."

About Rapid Medical

Rapid Medical is developing game-changing devices for neurovascular treatments.

Rapid Medical is the maker of TIGERTRIEVER(TM) and COMANECI(TM), the first-ever

adjustable remodeling mesh. TIGERTRIEVER and COMANECI are CE marked for use in

Europe and COMANECI is also FDA approved. More information is available at

www.rapid-medical.com

Contact:

Ronen Eckhouse

+972-72-2503331

ronen@rapid-medical.com

Source: Rapid Medical